Stem Cell Authority Cash Flow Statement

Financials in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Fiscal Year	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005
Period Ending	Aug '09 Aug 31, 2009	Aug '08 Aug 31, 2008	Aug '07 Aug 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005
Net Income	-	-	0.95	-0.66	-0.05
Depreciation & Amortization	-	-	0.01	-	-
Change in Inventory	-	-	-0.03	-	-
Change in Other Net Operating Assets	-	-	-0.05	-0.04	-
Operating Cash Flow	-	-	0.13	-0.7	-0.05
Capital Expenditures	-	-	-0.12	-	-
Investing Cash Flow	-	-	-0.12	-	-
Short-Term Debt Issued	-	-	-	0.67	0.05
Total Debt Issued	-	-	0.11	0.67	0.05
Total Debt Repaid	-	-	-0.01	-	-
Net Debt Issued (Repaid)	-	-	0.1	0.67	0.05
Issuance of Common Stock	-	-	0.01	0.03	-
Financing Cash Flow	-	-	0.11	0.7	0.05
Net Cash Flow	-	-	0.12	0	-
Free Cash Flow	-	-	0.01	-0.7	-0.05
Free Cash Flow Margin	-	-	1.28%	-	-
Free Cash Flow Per Share	-	-	-	-0.01	-0.00
Levered Free Cash Flow	-	-	-	-0.35	-
Unlevered Free Cash Flow	-	-	-	-0.33	-
Change in Working Capital	-	-	-0.84	-0.04	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.